58 related articles for article (PubMed ID: 10412790)
1. Gender-Dependent Associations between Serum Betatrophin Levels and Lipoprotein Subfractions in Diabetic and Nondiabetic Obese Patients.
Lőrincz H; Csiha S; Ratku B; Somodi S; Sztanek F; Seres I; Paragh G; Harangi M
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003693
[TBL] [Abstract][Full Text] [Related]
2. Modification of lipoprotein metabolism and function driving atherogenesis in diabetes.
Luciani L; Pedrelli M; Parini P
Atherosclerosis; 2024 Jul; 394():117545. PubMed ID: 38688749
[TBL] [Abstract][Full Text] [Related]
3. High hydrostatic pressure specifically affects molecular dynamics and shape of low-density lipoprotein particles.
Golub M; Lehofer B; Martinez N; Ollivier J; Kohlbrecher J; Prassl R; Peters J
Sci Rep; 2017 Apr; 7():46034. PubMed ID: 28382948
[TBL] [Abstract][Full Text] [Related]
4. Disorders of lipid metabolism and chronic kidney disease in the elderly.
Choudhury D; Tuncel M; Levi M
Semin Nephrol; 2009 Nov; 29(6):610-20. PubMed ID: 20006793
[TBL] [Abstract][Full Text] [Related]
5. Effect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study.
Fellström B; Zannad F; Schmieder R; Holdaas H; Jardine A; Rose H; Wilpshaar W;
Curr Control Trials Cardiovasc Med; 2005 May; 6(1):9. PubMed ID: 15910680
[TBL] [Abstract][Full Text] [Related]
6. Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients.
Piperi C; Kalofoutis C; Tzivras M; Troupis T; Skenderis A; Kalofoutis A
Mol Cell Biochem; 2004 Oct; 265(1-2):57-61. PubMed ID: 15543934
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of Diabetic Dyslipidemia.
Hirano T
J Atheroscler Thromb; 2018 Sep; 25(9):771-782. PubMed ID: 29998913
[TBL] [Abstract][Full Text] [Related]
8. Non-insulin-dependent diabetes mellitus and hypertriglyceridemia impair lipoprotein metabolism in chronic hemodialysis patients.
Quaschning T; Schömig M; Keller M; Thiery J; Nauck M; Schollmeyer P; Wanner C; Krämer-Guth A
J Am Soc Nephrol; 1999 Feb; 10(2):332-41. PubMed ID: 10215333
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression enhances atherogenicity of lipid profile after transplantation.
Quaschning T; Mainka T; Nauck M; Rump LC; Wanner C; Krämer-Guth A
Kidney Int Suppl; 1999 Jul; 71():S235-7. PubMed ID: 10412786
[TBL] [Abstract][Full Text] [Related]
10. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph
Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494
[TBL] [Abstract][Full Text] [Related]
11. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.
Guérin M; Le Goff W; Lassel TS; Van Tol A; Steiner G; Chapman MJ
Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):282-8. PubMed ID: 11156866
[TBL] [Abstract][Full Text] [Related]
12. Diabetic dyslipidemia.
Kreisberg RA
Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities in lipoprotein metabolism in hemodialysis patients.
Königer M; Quaschning T; Wanner C; Schollmeyer P; Krämer-Guth A
Kidney Int Suppl; 1999 Jul; 71():S248-50. PubMed ID: 10412790
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]